Article Versions Notes

Gu W, Mo S, Wang Y, Kawabata-Iwakawa R, Zhang W, Yang Z, Sun C, Tsushima Y, Xu H, Nakajima T. Robust Validation and Comprehensive Analysis of a Novel Signature Derived from Crucial Metabolic Pathways of Pancreatic Ductal Adenocarcinoma. Cancers. 2022; 14(7):1825. https://doi.org/10.3390/cancers14071825

Gu, Wenchao, Shaocong Mo, Yulin Wang, Reika Kawabata-Iwakawa, Wei Zhang, Zongcheng Yang, Chenyu Sun, Yoshito Tsushima, Huaxiang Xu, and Takahito Nakajima. 2022. "Robust Validation and Comprehensive Analysis of a Novel Signature Derived from Crucial Metabolic Pathways of Pancreatic Ductal Adenocarcinoma" Cancers 14, no. 7: 1825. https://doi.org/10.3390/cancers14071825

Gu, W., Mo, S., Wang, Y., Kawabata-Iwakawa, R., Zhang, W., Yang, Z., Sun, C., Tsushima, Y., Xu, H., & Nakajima, T. (2022). Robust Validation and Comprehensive Analysis of a Novel Signature Derived from Crucial Metabolic Pathways of Pancreatic Ductal Adenocarcinoma. Cancers, 14(7), 1825. https://doi.org/10.3390/cancers14071825